Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The International Journal of Biochemistry & Cell Biology|January 20, 2019
Hsa-miR-5195-3P induces downregulation of TGFβR1, TGFβR2, SMAD3 and SMAD4 supporting its tumor suppressive activity in HCT116 cellsMahnaz Jahangiri Moez, Hassan Bjeije, Bahram M SoltaniHuman Molecular Genetics|June 26, 2019
YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cellsHassan Bjeije, Bahram Mohammad Soltani, Mehrdad Behmanesh, et al.Journal of Neurogenetics|August 22, 2024
Oncogenic roles of long non-coding RNAs in essential glioblastoma signaling pathwaysMina Lashkarboloki, Amin Jahanbakhshi, Seyed Javad Mowla, et al.Journal of Cell Communication and Signaling|November 14, 2016
ROS mediates interferon gamma induced phosphorylation of Src, through the Raf/ERK pathway, in MCF-7 human breast cancer cell lineKazem Zibara, Asad Zeidan, Hassan Bjeije, et al.Biorxiv : the Preprint Server for Biology|August 12, 2025
Functional Comparison to Ezh2 Reveals PRC2-Independent Functions of Jarid2 in Hematopoietic Stem Cell Lineage CommitmentHassan Bjeije, Wentao Han, Nancy Issa, et al.Stem Cell Reports|February 6, 2026
Comparison with Ezh2 reveals the PRC2-dependent functions of Jarid2 in hematopoietic stem Cell lineage commitmentHassan Bjeije, Wentao Han, Shuyang Lin, et al.Leukemia|February 16, 2023
KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stressNancy Issa, Hassan Bjeije, Elisabeth R Wilson, et al.Biorxiv : the Preprint Server for Biology|September 15, 2025
JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow TransplantationWentao Han, Hassan Bjeije, Hamza Celik, et al.Cell Stem Cell|July 18, 2025
Non-canonical functions of DNMT3A in hematopoietic stem cells regulate telomerase activity and genome integrityInfencia Xavier Raj, Won Kyun Koh, Jessica Harrison, et al.Cancer Discovery|July 1, 2021
A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative NeoplasmsHamza Celik, Ethan Krug, Christine R Zhang, et al.Pageof 2